Pharming Group N.V. Equity And Liabilities
Pharming Group N.V. (PHAR) had Equity And Liabilities of $499.96 million as of 2025-12-31, per its 20-F filed 2026-04-02.
Financial Statements › Notes
ifrs-full:EquityAndLiabilities · last filed 2026-04-02
- 2020-12-31: Equity And Liabilities 340.76M EUR.
- 2019-12-31: Equity And Liabilities 228.21M EUR.
EUR
| Period end | Equity And Liabilities |
|---|---|
| 2020-12-31 | 340.76M EUR 20-F · filed 2021-04-07 |
| 2019-12-31 | 228.21M EUR 20-F · filed 2021-04-07 |
USD
| Period end | Equity And Liabilities |
|---|---|
| 2025-12-31 | $499.96M 20-F · filed 2026-04-02 |
| 2024-12-31 | $399.99M 20-F · filed 2026-04-02 |
| 2023-12-31 | $462.85M 20-F · filed 2025-04-03 |
| 2022-12-31 | $425.80M 20-F · filed 2024-04-04 |
| 2021-12-31 | $397.31M 20-F · filed 2023-04-05 |
| 2020-12-31 | $418.45M 20-F · filed 2022-04-06 |
| 2019-12-31 | $255.91M 20-F · filed 2022-04-06 |